Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2020

01-08-2020 | Research Article

Community pharmacists’ professional practices for complementary medicines: a qualitative study in New Zealand

Authors: Joanne Barnes, Rachael Butler

Published in: International Journal of Clinical Pharmacy | Issue 4/2020

Login to get access

Abstract

Background Complementary medicines are a popular healthcare choice among patients/consumers, and most pharmacies sell these products. Pharmacists are well-placed to advise on complementary medicines, but their training and practices for these products are not optimal. Pharmacists’ professional practices for complementary medicines ought to be influenced by professional codes of ethics and standards. Objective To examine community pharmacists’ perspectives on complementary medicines in New Zealand, including motivations and justifications for selling these products, and professional and ethical issues complementary medicines raise for pharmacists. Setting Community pharmacists in New Zealand. Method Qualitative, semi-structured interviews with 27 New Zealand practising community pharmacists identified through purposive and convenience sampling. Main outcome measure Participants’ views, experiences, and professional practices for complementary medicines. Results Participants struggled to clearly describe products they considered complementary medicines. Perspectives towards these products ranged from strongly supportive to somewhat sceptical; none was strongly opposed. Participants had several motivations for selling complementary medicines, particularly consumer demand and profits. Participants acknowledged ethical issues concerning complementary medicines, including lack of evidence of efficacy and pharmacists’ limited training/knowledge. Few referred explicitly to complementary-medicines-related statements in the Pharmacy Council of New Zealand's Code of Ethics, or indicated these guided their practice. Conclusion Participants sold complementary medicines despite having limited knowledge on these products and concerns about efficacy; participants justified this as they believe they are providing an holistic option for patients, and/or ensuring complementary medicines do no harm. Participants were mindful of ethical/professional issues regarding complementary medicines, but were not necessarily aware of, or guided by, explicit statements in the Pharmacy Council of New Zealand's Code of Ethics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–75.CrossRef Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–75.CrossRef
2.
go back to reference Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1–23. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1–23.
3.
go back to reference MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust. 2006;184(1):27–31.CrossRef MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust. 2006;184(1):27–31.CrossRef
4.
go back to reference Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50–3.CrossRef Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50–3.CrossRef
5.
go back to reference Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, et al. Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract. 2010;64(11):1496–502.CrossRef Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, et al. Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract. 2010;64(11):1496–502.CrossRef
6.
go back to reference Evans A, Duncan B, McHugh P, Shaw J, Wilson C. Inpatients' use, understanding, and attitudes towards traditional, complementary and alternative therapies at a provincial New Zealand hospital. N Z Med J. 2008;121(1278):21–34.PubMed Evans A, Duncan B, McHugh P, Shaw J, Wilson C. Inpatients' use, understanding, and attitudes towards traditional, complementary and alternative therapies at a provincial New Zealand hospital. N Z Med J. 2008;121(1278):21–34.PubMed
7.
go back to reference Nicholson T. Complementary and alternative medicines (including traditional Maori treatments) used by presenters to an emergency department in New Zealand: a survey of prevalence and toxicity. N Z Med J. 2006;119(1233):U1954.PubMed Nicholson T. Complementary and alternative medicines (including traditional Maori treatments) used by presenters to an emergency department in New Zealand: a survey of prevalence and toxicity. N Z Med J. 2006;119(1233):U1954.PubMed
8.
go back to reference Wilson K, Dowson C, Mangin D. Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients. N Z Med J. 2007;120(1251):U2464.PubMed Wilson K, Dowson C, Mangin D. Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients. N Z Med J. 2007;120(1251):U2464.PubMed
10.
go back to reference Barnes J, Abbot NC. Professional practices and experiences with complementary medicines: a cross-sectional study involving community pharmacists in England. Int J Pharm Pract. 2007;15(3):167–75.CrossRef Barnes J, Abbot NC. Professional practices and experiences with complementary medicines: a cross-sectional study involving community pharmacists in England. Int J Pharm Pract. 2007;15(3):167–75.CrossRef
11.
go back to reference Barnes J, Dong C. Professional practices and experiences with complementary medicines: a cross-sectional study involving community pharmacists in New Zealand. In: 15th International Social Pharmacy Workshop; 8–11 July 2008; Queenstown, New Zealand; 2008. Barnes J, Dong C. Professional practices and experiences with complementary medicines: a cross-sectional study involving community pharmacists in New Zealand. In: 15th International Social Pharmacy Workshop; 8–11 July 2008; Queenstown, New Zealand; 2008.
12.
go back to reference Gilbert L. Alternative medicine in the community pharmacy - A case study of community pharmacies in Johannesburg. South Africa J Soc Admin Pharm. 2002;19:72–80. Gilbert L. Alternative medicine in the community pharmacy - A case study of community pharmacies in Johannesburg. South Africa J Soc Admin Pharm. 2002;19:72–80.
13.
go back to reference Brown CM. Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas. J Am Pharm Assoc. 1998;38(5):603–8. Brown CM. Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas. J Am Pharm Assoc. 1998;38(5):603–8.
14.
go back to reference Brown CM, Barner JC, Shah S. Community pharmacists' actions when patients use complementary and alternative therapies with medications. J Am Pharm Assoc. 2005;45(1):41–7.CrossRef Brown CM, Barner JC, Shah S. Community pharmacists' actions when patients use complementary and alternative therapies with medications. J Am Pharm Assoc. 2005;45(1):41–7.CrossRef
15.
go back to reference Bouldin AS, Smith MC, Garner DD, Szeinbach SL, Frate DA, Croom EM. Pharmacy and herbal medicine in the US. Soc Sci Med. 1999;49(2):279–89.CrossRef Bouldin AS, Smith MC, Garner DD, Szeinbach SL, Frate DA, Croom EM. Pharmacy and herbal medicine in the US. Soc Sci Med. 1999;49(2):279–89.CrossRef
16.
go back to reference Semple SJ, Hotham E, Rao D, Martin K, Smith CA, Bloustien GF. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines. Pharm World Sci. 2006;28(6):366–73.CrossRef Semple SJ, Hotham E, Rao D, Martin K, Smith CA, Bloustien GF. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines. Pharm World Sci. 2006;28(6):366–73.CrossRef
17.
go back to reference Dolder C, Lacro J, Dolder N, Gregory P. Pharmacists' use of and attitudes and beliefs about alternative medications. Am J Health Syst Pharm. 2003;60(13):1352–7.CrossRef Dolder C, Lacro J, Dolder N, Gregory P. Pharmacists' use of and attitudes and beliefs about alternative medications. Am J Health Syst Pharm. 2003;60(13):1352–7.CrossRef
18.
go back to reference Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists' knowledge and attitudes toward herbal medicine. Ann Pharmacother. 2000;34(6):710–5.CrossRef Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists' knowledge and attitudes toward herbal medicine. Ann Pharmacother. 2000;34(6):710–5.CrossRef
19.
go back to reference Naidu S, Wilkinson JM, Simpson MD. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother. 2005;39(9):1456–61.CrossRef Naidu S, Wilkinson JM, Simpson MD. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother. 2005;39(9):1456–61.CrossRef
20.
go back to reference Koh HL, Teo HH, Ng HL. Pharmacists' patterns of use, knowledge, and attitudes toward complementary and alternative medicine. J Altern Complement Med. 2003;9(1):51–63.CrossRef Koh HL, Teo HH, Ng HL. Pharmacists' patterns of use, knowledge, and attitudes toward complementary and alternative medicine. J Altern Complement Med. 2003;9(1):51–63.CrossRef
21.
go back to reference Welna EM, Hadsall RS, Schommer JC. Pharmacists' personal use, professional practice behaviors, and perceptions regarding herbal and other natural products. J Am Pharm Assoc. 2003;43(5):602–11.CrossRef Welna EM, Hadsall RS, Schommer JC. Pharmacists' personal use, professional practice behaviors, and perceptions regarding herbal and other natural products. J Am Pharm Assoc. 2003;43(5):602–11.CrossRef
22.
go back to reference Howard N, Tsourounis C, Kapusnik-Uner J. Dietary supplement survey of pharmacists: personal and professional practices. J Altern Complement Med. 2001;7(6):667–80.CrossRef Howard N, Tsourounis C, Kapusnik-Uner J. Dietary supplement survey of pharmacists: personal and professional practices. J Altern Complement Med. 2001;7(6):667–80.CrossRef
23.
go back to reference Kanjanarach T, Krass I, Cumming RG. Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. Int J Pharm Pract. 2006;14(2):123–8.CrossRef Kanjanarach T, Krass I, Cumming RG. Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. Int J Pharm Pract. 2006;14(2):123–8.CrossRef
24.
go back to reference Pharmacy Council of New Zealand. Code of Ethics. Wellington: Pharmacy Council of New Zealand; 2004. Pharmacy Council of New Zealand. Code of Ethics. Wellington: Pharmacy Council of New Zealand; 2004.
25.
go back to reference Barnes J, McLachlan AJ, Sherwin CMT, Enioutina EY. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. Expert Rev Clin Pharmacol. 2016;9(7):905–15.CrossRef Barnes J, McLachlan AJ, Sherwin CMT, Enioutina EY. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. Expert Rev Clin Pharmacol. 2016;9(7):905–15.CrossRef
26.
go back to reference Barnes J, Butler R. Community pharmacists' views on the regulation of complementary medicines and complementary-medicines practitioners: a qualitative study in New Zealand. Int J Pharm Pract. 2018;26(6):485–93.CrossRef Barnes J, Butler R. Community pharmacists' views on the regulation of complementary medicines and complementary-medicines practitioners: a qualitative study in New Zealand. Int J Pharm Pract. 2018;26(6):485–93.CrossRef
27.
go back to reference Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–46.CrossRef Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–46.CrossRef
28.
go back to reference Barnes J, Anderson LA, Phillipson JD. Herbal medicines. A guide for health-care professionals. 3rd ed. London: Pharmaceutical Press; 2007. Barnes J, Anderson LA, Phillipson JD. Herbal medicines. A guide for health-care professionals. 3rd ed. London: Pharmaceutical Press; 2007.
37.
go back to reference Zoio N. Natural health products bill quietly killed off. Pharm Today [Internet]. 2017;December:13. Zoio N. Natural health products bill quietly killed off. Pharm Today [Internet]. 2017;December:13.
38.
go back to reference Culverhouse SE, Wohlmuth H. Factors affecting pharmacists' recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12:183.CrossRef Culverhouse SE, Wohlmuth H. Factors affecting pharmacists' recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12:183.CrossRef
39.
go back to reference Zeolla MM, Cerulli J. Use of and familiarity with dietary supplement information references by practicing pharmacists. J Am Pharm Assoc. 2008;48(3):401–13.CrossRef Zeolla MM, Cerulli J. Use of and familiarity with dietary supplement information references by practicing pharmacists. J Am Pharm Assoc. 2008;48(3):401–13.CrossRef
40.
go back to reference Bushett NJ, Dickson-Swift VA, Willis JA, Wood P. Rural Australian community pharmacists' views on complementary and alternative medicine: a pilot study. BMC Complement Altern Med. 2011;11(1):103.CrossRef Bushett NJ, Dickson-Swift VA, Willis JA, Wood P. Rural Australian community pharmacists' views on complementary and alternative medicine: a pilot study. BMC Complement Altern Med. 2011;11(1):103.CrossRef
41.
go back to reference Boon H, Hirschkorn K, Griener G, Cali M. The ethics of dietary supplements and natural health products in pharmacy practice: a systematic documentary analysis. Int J Pharm Pract. 2009;17(1):31–8.CrossRef Boon H, Hirschkorn K, Griener G, Cali M. The ethics of dietary supplements and natural health products in pharmacy practice: a systematic documentary analysis. Int J Pharm Pract. 2009;17(1):31–8.CrossRef
42.
go back to reference Ung COL, Harnett J, Hu H. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience. BMC Complement Altern Med. 2017;17(1):394.CrossRef Ung COL, Harnett J, Hu H. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience. BMC Complement Altern Med. 2017;17(1):394.CrossRef
43.
go back to reference Ung COL, Harnett J, Hu H. Development of a strategic model for integrating complementary medicines into professional pharmacy practice. Res Soc Admin Pharm. 2018;14:663–72.CrossRef Ung COL, Harnett J, Hu H. Development of a strategic model for integrating complementary medicines into professional pharmacy practice. Res Soc Admin Pharm. 2018;14:663–72.CrossRef
44.
go back to reference Olatunde S, Boon H, Hirschkorn K, Welsh S, Bajcar J. Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews. Res Social Adm Pharm. 2010;6(1):63–9.CrossRef Olatunde S, Boon H, Hirschkorn K, Welsh S, Bajcar J. Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews. Res Social Adm Pharm. 2010;6(1):63–9.CrossRef
45.
go back to reference Kwan D, Boon HS, Hirschkorn K, Welsh S, Jurgens T, Eccott L, et al. Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups. BMC Complement Altern Med. 2008;8:40.CrossRef Kwan D, Boon HS, Hirschkorn K, Welsh S, Jurgens T, Eccott L, et al. Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups. BMC Complement Altern Med. 2008;8:40.CrossRef
46.
go back to reference Braun LA, Tiralongo E, Wilkinson JM, Spitzer O, Bailey M, Poole S, et al. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med. 2010;10:38.CrossRef Braun LA, Tiralongo E, Wilkinson JM, Spitzer O, Bailey M, Poole S, et al. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med. 2010;10:38.CrossRef
47.
go back to reference Ung COL, Harnett J, Hu H. Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: a systematic literature review. Res Social Adm Pharm. 2017;13(4):686–716.CrossRef Ung COL, Harnett J, Hu H. Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: a systematic literature review. Res Social Adm Pharm. 2017;13(4):686–716.CrossRef
48.
go back to reference Tran S, Calabretto JP, Sorich M. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence. Int J Pharm Pract. 2013;21(6):378–85.CrossRef Tran S, Calabretto JP, Sorich M. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence. Int J Pharm Pract. 2013;21(6):378–85.CrossRef
Metadata
Title
Community pharmacists’ professional practices for complementary medicines: a qualitative study in New Zealand
Authors
Joanne Barnes
Rachael Butler
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01093-2

Other articles of this Issue 4/2020

International Journal of Clinical Pharmacy 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.